The regulation of inflammation by interferons and their STATs

References

• Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428 - 35; http://dx.doi.org/10.1038/nature07201; PMID: 18650913
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140:771 - 6; http://dx.doi.org/10.1016/j.cell.2010.03.006; PMID: 20303867
   PubMed Web of Science ®Google Scholar
• Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202:8 - 32; http://dx.doi.org/10.1111/j.0105-2896.2004.00204.x; PMID: 15546383
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 2010; 30:555 - 64; http://dx.doi.org/10.1089/jir.2010.0078; PMID: 20712453
   PubMed Web of Science ®Google Scholar
• Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163 - 89; http://dx.doi.org/10.1189/jlb.0603252; PMID: 14525967
   PubMed Web of Science ®Google Scholar
• Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 2010; 207:2703 - 17; http://dx.doi.org/10.1084/jem.20092720; PMID: 20975040
   PubMed Web of Science ®Google Scholar
• Osterlund PI, Pietilä TE, Veckman V, Kotenko SV, Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 2007; 179:3434 - 42; PMID: 17785777
   PubMed Web of Science ®Google Scholar
• Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6:975 - 90; http://dx.doi.org/10.1038/nrd2422; PMID: 18049472
   PubMed Web of Science ®Google Scholar
• Levy DE, Darnell JEJ Jr.. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3:651 - 62; http://dx.doi.org/10.1038/nrm909; PMID: 12209125
   PubMed Web of Science ®Google Scholar
• Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000; 13:795 - 804; http://dx.doi.org/10.1016/S1074-7613(00)00077-7; PMID: 11163195
   PubMed Web of Science ®Google Scholar
• Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008; 9:378 - 87; http://dx.doi.org/10.1038/ni1576; PMID: 18345002
   PubMed Web of Science ®Google Scholar
• Gough DJ, Messina NL, Clarke CJP, Johnstone RW, Levy DE. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012; 36:166 - 74; http://dx.doi.org/10.1016/j.immuni.2012.01.011; PMID: 22365663
   PubMed Web of Science ®Google Scholar
• Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171 - 86; http://dx.doi.org/10.1016/j.immuni.2012.05.020; PMID: 22749822
   PubMed Web of Science ®Google Scholar
• Essers MAG, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458:904 - 8; http://dx.doi.org/10.1038/nature07815; PMID: 19212321
   PubMed Web of Science ®Google Scholar
• Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009; 15:696 - 700; http://dx.doi.org/10.1038/nm.1973; PMID: 19483695
   PubMed Web of Science ®Google Scholar
• Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010; 465:793 - 7; http://dx.doi.org/10.1038/nature09135; PMID: 20535209
   PubMed Web of Science ®Google Scholar
• Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A, et al. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 2002; 277:7726 - 35; http://dx.doi.org/10.1074/jbc.M106640200; PMID: 11773065
   PubMed Web of Science ®Google Scholar
• Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, et al. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012; 36:1047 - 59; http://dx.doi.org/10.1016/j.immuni.2012.03.026; PMID: 22749354
   PubMed Web of Science ®Google Scholar
• Stockinger S, Decker T. Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 2008; 213:889 - 97; http://dx.doi.org/10.1016/j.imbio.2008.07.020; PMID: 18926303
   PubMed Web of Science ®Google Scholar
• Broz P, Monack DM. Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 2011; 243:174 - 90; http://dx.doi.org/10.1111/j.1600-065X.2011.01041.x; PMID: 21884176
   PubMed Web of Science ®Google Scholar
• Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012; 13:954 - 62; http://dx.doi.org/10.1038/ni.2397; PMID: 22922364
   PubMed Web of Science ®Google Scholar
• Navarini AA, Recher M, Lang KS, Georgiev P, Meury S, Bergthaler A, et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A 2006; 103:15535 - 9; http://dx.doi.org/10.1073/pnas.0607325103; PMID: 17030789
   PubMed Web of Science ®Google Scholar
• Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119:1910 - 20; http://dx.doi.org/10.1172/JCI35412; PMID: 19487810
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Type I interferon: friend or foe?. J Exp Med 2010; 207:2053 - 63; http://dx.doi.org/10.1084/jem.20101664; PMID: 20837696
   PubMed Web of Science ®Google Scholar
• Carrero JA, Unanue ER. Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol 2006; 27:497 - 503; http://dx.doi.org/10.1016/j.it.2006.09.005; PMID: 16997632
   PubMed Web of Science ®Google Scholar
• Kernbauer E, Maier V, Stoiber D, Strobl B, Schneckenleithner C, Sexl V, et al. Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection. PLoS Pathog 2012; 8:e1002763; http://dx.doi.org/10.1371/journal.ppat.1002763; PMID: 22719255
   PubMedGoogle Scholar
• Huys L, Van Hauwermeiren F, Dejager L, Dejonckheere E, Lienenklaus S, Weiss S, et al. Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med 2009; 206:1873 - 82; http://dx.doi.org/10.1084/jem.20090213; PMID: 19687227
   PubMed Web of Science ®Google Scholar
• Decker T, Müller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 2005; 5:675 - 87; http://dx.doi.org/10.1038/nri1684; PMID: 16110316
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610 - 21; http://dx.doi.org/10.1056/NEJMra052723; PMID: 16467548
   PubMed Web of Science ®Google Scholar
• Zhou ZH, Chaturvedi P, Han YL, Aras S, Li YS, Kolattukudy PE, et al. IFN-gamma induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: functional interaction between an IFN-gamma-activated site and a GC-rich element. J Immunol 1998; 160:3908 - 16; PMID: 9558097
   PubMed Web of Science ®Google Scholar
• Majumder S, Zhou LZ, Chaturvedi P, Babcock G, Aras S, Ransohoff RM. p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha. J Immunol 1998; 161:4736 - 44; PMID: 9794404
   PubMed Web of Science ®Google Scholar
• Kim M-O, Suh H-S, Brosnan CF, Lee SC. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta. J Neurochem 2004; 90:297 - 308; http://dx.doi.org/10.1111/j.1471-4159.2004.02487.x; PMID: 15228586
   PubMed Web of Science ®Google Scholar
• Wong P, Severns CW, Guyer NB, Wright TM. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol Cell Biol 1994; 14:914 - 22; PMID: 8289831
   PubMed Web of Science ®Google Scholar
• Conrady CD, Zheng M, Mandal NA, van Rooijen N, Carr DJJ. IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice. Mucosal Immunol 2013; 6:45 - 55; http://dx.doi.org/10.1038/mi.2012.46; PMID: 22692455
   PubMed Web of Science ®Google Scholar
• Liu J, Guan X, Ma X. Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon γ-induced RANTES/CCl5 expression in macrophages. J Biol Chem 2005; 280:24347 - 55; http://dx.doi.org/10.1074/jbc.M500973200; PMID: 15860458
   PubMed Web of Science ®Google Scholar
• Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998; 187:2009 - 21; http://dx.doi.org/10.1084/jem.187.12.2009; PMID: 9625760
   PubMed Web of Science ®Google Scholar
• Hiroi M, Ohmori Y. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-κ B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-γ gene. J Biol Chem 2003; 278:651 - 60; http://dx.doi.org/10.1074/jbc.M204544200; PMID: 12403783
   PubMed Web of Science ®Google Scholar
• Ohmori Y, Hamilton TA. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol 1995; 154:5235 - 44; PMID: 7730628
   PubMed Web of Science ®Google Scholar
• Ohmori Y, Schreiber RD, Hamilton TA. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 1997; 272:14899 - 907; http://dx.doi.org/10.1074/jbc.272.23.14899; PMID: 9169460
   PubMed Web of Science ®Google Scholar
• Pietilä TE, Veckman V, Lehtonen A, Lin R, Hiscott J, Julkunen I. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J Immunol 2007; 178:253 - 61; PMID: 17182562
   PubMed Web of Science ®Google Scholar
• Ellis SL, Gysbers V, Manders PM, Li W, Hofer MJ, Müller M, et al. The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. J Immunol 2010; 185:1864 - 77; http://dx.doi.org/10.4049/jimmunol.1000900; PMID: 20585034
   PubMed Web of Science ®Google Scholar
• Jia T, Leiner I, Dorothee G, Brandl K, Pamer EG. MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J Immunol 2009; 183:1271 - 8; http://dx.doi.org/10.4049/jimmunol.0900460; PMID: 19553532
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958 - 69; http://dx.doi.org/10.1038/nri2448; PMID: 19029990
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177:7303 - 11; PMID: 17082649
   PubMed Web of Science ®Google Scholar
• Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999; 163:1537 - 44; PMID: 10415057
   PubMed Web of Science ®Google Scholar
• Zimmerer JM, Lesinski GB, Radmacher MD, Ruppert A, Carson WE 3rd. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol Immunother 2007; 56:1845 - 52; http://dx.doi.org/10.1007/s00262-007-0329-9; PMID: 17503042
   PubMed Web of Science ®Google Scholar
• Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001; 112:174 - 80; http://dx.doi.org/10.1016/S0165-5728(00)00397-0; PMID: 11108946
   PubMed Web of Science ®Google Scholar
• Aung LL, Fitzgerald-Bocarsly P, Dhib-Jalbut S, Balashov K. Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta. J Neuroimmunol 2010; 226:158 - 64; http://dx.doi.org/10.1016/j.jneuroim.2010.06.008; PMID: 20621365
   PubMed Web of Science ®Google Scholar
• Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000; 105:985 - 93; http://dx.doi.org/10.1172/JCI9232; PMID: 10749577
   PubMed Web of Science ®Google Scholar
• Salazar-Mather TP, Lewis CA, Biron CA. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 2002; 110:321 - 30; PMID: 12163451
   PubMed Web of Science ®Google Scholar
• Crane MJ, Hokeness-Antonelli KL, Salazar-Mather TP. Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol 2009; 183:2810 - 7; http://dx.doi.org/10.4049/jimmunol.0900205; PMID: 19620305
   PubMed Web of Science ®Google Scholar
• Pietras EM, Miller LS, Johnson CT, O’Connell RM, Dempsey PW, Cheng GA. A MyD88-dependent IFNγR-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge. Cell Res 2011; 21:1068 - 79; http://dx.doi.org/10.1038/cr.2011.59; PMID: 21467996
   PubMed Web of Science ®Google Scholar
• Kelly-Scumpia KM, Scumpia PO, Delano MJ, Weinstein JS, Cuenca AG, Wynn JL, et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med 2010; 207:319 - 26; http://dx.doi.org/10.1084/jem.20091959; PMID: 20071504
   PubMed Web of Science ®Google Scholar
• Pasieka TJ, Cilloniz C, Carter VS, Rosato P, Katze MG, Leib DA. Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection. J Virol 2011; 85:12972 - 81; http://dx.doi.org/10.1128/JVI.06032-11; PMID: 21994441
   PubMed Web of Science ®Google Scholar
• Lin AA, Tripathi PK, Sholl A, Jordan MB, Hildeman DA. Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J Virol 2009; 83:8604 - 15; http://dx.doi.org/10.1128/JVI.02477-08; PMID: 19515766
   PubMed Web of Science ®Google Scholar
• Kimura H, Kimura M, Rose NR, Caturegli P. Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto’s thyroiditis. Exp Mol Pathol 2004; 77:161 - 7; http://dx.doi.org/10.1016/j.yexmp.2004.08.004; PMID: 15507231
   PubMed Web of Science ®Google Scholar
• Glabinski AR, Krakowski M, Han Y, Owens T, Ransohoff RM. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis. J Neurovirol 1999; 5:95 - 101; http://dx.doi.org/10.3109/13550289909029750; PMID: 10190695
   PubMed Web of Science ®Google Scholar
• Fulkerson PC, Zimmermann N, Hassman LM, Finkelman FD, Rothenberg ME. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol 2004; 173:7565 - 74; PMID: 15585884
   PubMed Web of Science ®Google Scholar
• Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, et al. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest 2012; 122:575 - 85; http://dx.doi.org/10.1172/JCI61034; PMID: 22251703
   PubMed Web of Science ®Google Scholar
• Tessitore A, Pastore L, Rispoli A, Cilenti L, Toniato E, Flati V, et al. Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-gamma. Eur J Biochem 1998; 258:968 - 75; http://dx.doi.org/10.1046/j.1432-1327.1998.2580968.x; PMID: 9990314
   PubMedGoogle Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23 - 35; http://dx.doi.org/10.1038/nri978; PMID: 12511873
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5:953 - 64; http://dx.doi.org/10.1038/nri1733; PMID: 16322748
   PubMed Web of Science ®Google Scholar
• Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327:656 - 61; http://dx.doi.org/10.1126/science.1178331; PMID: 20133564
   PubMed Web of Science ®Google Scholar
• Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003; 19:59 - 70; http://dx.doi.org/10.1016/S1074-7613(03)00171-7; PMID: 12871639
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2:907 - 16; http://dx.doi.org/10.1038/ni1001-907; PMID: 11577346
   PubMed Web of Science ®Google Scholar
• Kleinert H, Schwarz PM, Förstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003; 384:1343 - 64; http://dx.doi.org/10.1515/BC.2003.152; PMID: 14669979
   PubMed Web of Science ®Google Scholar
• Farlik M, Reutterer B, Schindler C, Greten F, Vogl C, Müller M, et al. Nonconventional initiation complex assembly by STAT and NF-kappaB transcription factors regulates nitric oxide synthase expression. Immunity 2010; 33:25 - 34; http://dx.doi.org/10.1016/j.immuni.2010.07.001; PMID: 20637660
   PubMed Web of Science ®Google Scholar
• Tschopp J, Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol 2010; 10:210 - 5; http://dx.doi.org/10.1038/nri2725; PMID: 20168318
   PubMed Web of Science ®Google Scholar
• Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011; 34:213 - 23; http://dx.doi.org/10.1016/j.immuni.2011.02.006; PMID: 21349431
   PubMed Web of Science ®Google Scholar
• Mishra BB, Rathinam VAK, Martens GW, Martinot AJ, Kornfeld H, Fitzgerald KA, et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol 2013; 14:52 - 60; http://dx.doi.org/10.1038/ni.2474; PMID: 23160153
   PubMed Web of Science ®Google Scholar
• Majer O, Bourgeois C, Zwolanek F, Lassnig C, Kerjaschki D, Mack M, et al. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog 2012; 8:e1002811; http://dx.doi.org/10.1371/journal.ppat.1002811; PMID: 22911155
   PubMed Web of Science ®Google Scholar
• Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med 1990; 171:1853 - 69; http://dx.doi.org/10.1084/jem.171.6.1853; PMID: 2112583
   PubMed Web of Science ®Google Scholar
• Heinzel FP. The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145:2920 - 4; PMID: 2120341
   PubMed Web of Science ®Google Scholar
• Karaghiosoff M, Steinborn R, Kovarik P, Kriegshäuser G, Baccarini M, Donabauer B, et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003; 4:471 - 7; http://dx.doi.org/10.1038/ni910; PMID: 12679810
   PubMed Web of Science ®Google Scholar
• Thomas KE, Galligan CL, Newman RD, Fish EN, Vogel SN. Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem 2006; 281:31119 - 30; http://dx.doi.org/10.1074/jbc.M604958200; PMID: 16912041
   PubMed Web of Science ®Google Scholar
• Perry ST, Buck MD, Lada SM, Schindler C, Shresta S. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog 2011; 7:e1001297; http://dx.doi.org/10.1371/journal.ppat.1001297; PMID: 21379341
   PubMed Web of Science ®Google Scholar
• Mahieu T, Libert C. Should we inhibit type I interferons in sepsis?. Infect Immun 2007; 75:22 - 9; http://dx.doi.org/10.1128/IAI.00829-06; PMID: 17000722
   PubMed Web of Science ®Google Scholar
• Weighardt H, Kaiser-Moore S, Schlautkötter S, Rossmann-Bloeck T, Schleicher U, Bogdan C, et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol 2006; 177:5623 - 30; PMID: 17015750
   PubMed Web of Science ®Google Scholar
• Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, Sherwood ER. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Shock 2012; 38:395 - 402; http://dx.doi.org/10.1097/SHK.0b013e318265a2ab; PMID: 22777121
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298 - 306; http://dx.doi.org/10.1038/nature10208; PMID: 21677746
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Ghosh S, Panes J, Vranic I, Su C, Rousell S, et al, Study A3921063 Investigators. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med 2012; 367:616 - 24; http://dx.doi.org/10.1056/NEJMoa1112168; PMID: 22894574
   PubMed Web of Science ®Google Scholar
• Kühbacher T, Gionchetti P, Hampe J, Helwig U, Rosenstiel P, Campieri M, et al. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001; 123:395 - 401; http://dx.doi.org/10.1046/j.1365-2249.2001.01455.x; PMID: 11298125
   PubMed Web of Science ®Google Scholar
• Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002; 51:379 - 85; http://dx.doi.org/10.1136/gut.51.3.379; PMID: 12171960
   PubMed Web of Science ®Google Scholar
• Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 2005; 100:64 - 72; http://dx.doi.org/10.1111/j.1572-0241.2005.40615.x; PMID: 15654782
   PubMed Web of Science ®Google Scholar
• Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, et al. Genome-wide gene expression differences in Crohn’s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007; 13:807 - 21; http://dx.doi.org/10.1002/ibd.20110; PMID: 17262812
   PubMed Web of Science ®Google Scholar
• Leal RF, Ayrizono MLS, Milanski M, Coope A, Fagundes JJ, Velloso LA, et al. Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-γ and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Clin Exp Immunol 2010; 160:380 - 5; http://dx.doi.org/10.1111/j.1365-2249.2009.04088.x; PMID: 20345984
   PubMed Web of Science ®Google Scholar
• Christophi GP, Rong R, Holtzapple PG, Massa PT, Landas SK. Immune markers and differential signaling networks in ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis 2012; 18:2342 - 56; http://dx.doi.org/10.1002/ibd.22957; PMID: 22467146
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay SK, de la Motte CA, Kessler SP, Hascall VC, Hill DR, Strong SA. Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1. Am J Pathol 2008; 173:1361 - 8; http://dx.doi.org/10.2353/ajpath.2008.080444; PMID: 18818378
   PubMed Web of Science ®Google Scholar
• Berry D, Schwab C, Milinovich G, Reichert J, Ben Mahfoudh K, Decker T, et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J 2012; 6:2091 - 106; http://dx.doi.org/10.1038/ismej.2012.39; PMID: 22572638
   PubMed Web of Science ®Google Scholar
• Kalim KW, Basler M, Kirk CJ, Groettrup M. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. J Immunol 2012; 189:4182 - 93; http://dx.doi.org/10.4049/jimmunol.1201183; PMID: 22984077
   PubMed Web of Science ®Google Scholar
• Takahashi R, Nishimoto S, Muto G, Sekiya T, Tamiya T, Kimura A, et al. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production. J Exp Med 2011; 208:2055 - 67; http://dx.doi.org/10.1084/jem.20110428; PMID: 21893603
   PubMed Web of Science ®Google Scholar
• Wu X, Guo W, Wu L, Gu Y, Gu L, Xu S, et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol 2012; 189:3497 - 507; http://dx.doi.org/10.4049/jimmunol.1201006; PMID: 22942432
   PubMed Web of Science ®Google Scholar
• Costantino G, Egerbacher M, Kolbe T, Karaghiosoff M, Strobl B, Vogl C, et al. Tyk2 and signal transducer and activator of transcription 1 contribute to intestinal I/R injury. Shock 2008; 29:238 - 44; PMID: 17693920
   PubMed Web of Science ®Google Scholar
• Mazzarella G, MacDonald TT, Salvati VM, Mulligan P, Pasquale L, Stefanile R, et al. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. Am J Pathol 2003; 162:1845 - 55; http://dx.doi.org/10.1016/S0002-9440(10)64319-2; PMID: 12759242
   PubMed Web of Science ®Google Scholar
• Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW 4th. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003; 299:1575 - 8; http://dx.doi.org/10.1126/science.1077905; PMID: 12624267
   PubMed Web of Science ®Google Scholar
• Vancott JL, McNeal MM, Choi AHC, Ward RL. The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res 2003; 23:163 - 70; http://dx.doi.org/10.1089/107999003321532501; PMID: 12716489
   PubMed Web of Science ®Google Scholar
• Pott J, Mahlakõiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, et al. IFN-λ determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 2011; 108:7944 - 9; http://dx.doi.org/10.1073/pnas.1100552108; PMID: 21518880
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261 - 70; PMID: 8757634
   PubMed Web of Science ®Google Scholar
• Reinisch W, Sandborn WJ, Hommes DW, D’Haens GR, Hanauer SB, Schrieber S, et al. 847t Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis. Gastroenterology 2010; 138:S114 - 5; http://dx.doi.org/10.1016/S0016-5085(10)60526-4
   Google Scholar
• Hommes DW, Mikhajlova TL, Stoinov S, Stimac D, Vucelic B, Lonovics J, et al. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn’s disease. Gut 2006; 55:1131 - 7; http://dx.doi.org/10.1136/gut.2005.079392; PMID: 16507585
   PubMed Web of Science ®Google Scholar
• Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994; 1:553 - 62; http://dx.doi.org/10.1016/1074-7613(94)90045-0; PMID: 7600284
   PubMed Web of Science ®Google Scholar
• Obermeier F, Kojouharoff G, Hans W, Schölmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116:238 - 45; http://dx.doi.org/10.1046/j.1365-2249.1999.00878.x; PMID: 10337013
   PubMed Web of Science ®Google Scholar
• Hans W, Schölmerich J, Gross V, Falk W. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw 2000; 11:67 - 74; PMID: 10705301
   PubMed Web of Science ®Google Scholar
• Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 2006; 146:330 - 8; http://dx.doi.org/10.1111/j.1365-2249.2006.03214.x; PMID: 17034586
   PubMed Web of Science ®Google Scholar
• Nava P, Koch S, Laukoetter MG, Lee WY, Kolegraff K, Capaldo CT, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 2010; 32:392 - 402; http://dx.doi.org/10.1016/j.immuni.2010.03.001; PMID: 20303298
   PubMed Web of Science ®Google Scholar
• Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, Aoshi T, et al. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol 2003; 18:578 - 87; http://dx.doi.org/10.1046/j.1440-1746.2003.03024.x; PMID: 12702051
   PubMed Web of Science ®Google Scholar
• Camoglio L, te Velde AA, de Boer A, ten Kate FJ, Kopf M, van Deventer SJ. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol 2000; 30:1486 - 95; http://dx.doi.org/10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8; PMID: 10820397
   PubMed Web of Science ®Google Scholar
• Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189:1169 - 80; http://dx.doi.org/10.1084/jem.189.8.1169; PMID: 10209035
   PubMed Web of Science ®Google Scholar
• Sheikh SZ, Matsuoka K, Kobayashi T, Li F, Rubinas T, Plevy SE. Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol 2010; 184:4069 - 73; http://dx.doi.org/10.4049/jimmunol.0903600; PMID: 20228197
   PubMed Web of Science ®Google Scholar
• González-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12:125 - 35; PMID: 22222875
   PubMed Web of Science ®Google Scholar
• Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, et al. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J Immunol 2012; 188:2001 - 13; http://dx.doi.org/10.4049/jimmunol.1100765; PMID: 22250092
   PubMed Web of Science ®Google Scholar
• Lee SE, Li X, Kim JCK, Lee J, González-Navajas JM, Hong SH, et al. Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice. Gastroenterology 2012; 143:145 - 54; http://dx.doi.org/10.1053/j.gastro.2012.03.042; PMID: 22475534
   PubMed Web of Science ®Google Scholar
• Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25:383 - 92; http://dx.doi.org/10.1016/j.immuni.2006.08.010; PMID: 16979570
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100:2610 - 5; http://dx.doi.org/10.1073/pnas.0337679100; PMID: 12604793
   PubMed Web of Science ®Google Scholar
• Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197:711 - 23; http://dx.doi.org/10.1084/jem.20021553; PMID: 12642603
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Alm GV, Eloranta M-L. Type I interferon and lupus. Curr Opin Rheumatol 2009; 21:471 - 7; http://dx.doi.org/10.1097/BOR.0b013e32832e089e; PMID: 19525849
   PubMed Web of Science ®Google Scholar
• Triantafyllopoulou A, Franzke C-W, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A 2010; 107:3012 - 7; http://dx.doi.org/10.1073/pnas.0914902107; PMID: 20133703
   PubMed Web of Science ®Google Scholar
• Agrawal H, Jacob N, Carreras E, Bajana S, Putterman C, Turner S, et al. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol 2009; 183:6021 - 9; http://dx.doi.org/10.4049/jimmunol.0803872; PMID: 19812195
   PubMed Web of Science ®Google Scholar
• Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, et al. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1785 - 96; http://dx.doi.org/10.1002/art.24557; PMID: 19479852
   PubMed Web of Science ®Google Scholar
• Thibault DL, Chu AD, Graham KL, Balboni I, Lee LY, Kohlmoos C, et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest 2008; 118:1417 - 26; http://dx.doi.org/10.1172/JCI30065; PMID: 18340381
   PubMed Web of Science ®Google Scholar
• Jego G, Palucka AK, Blanck J-P, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19:225 - 34; http://dx.doi.org/10.1016/S1074-7613(03)00208-5; PMID: 12932356
   PubMed Web of Science ®Google Scholar
• Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009; 206:1983 - 94; http://dx.doi.org/10.1084/jem.20090480; PMID: 19703986
   PubMed Web of Science ®Google Scholar
• Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher LH, Kuchroo VK. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004; 200:79 - 87; http://dx.doi.org/10.1084/jem.20031819; PMID: 15238607
   PubMed Web of Science ®Google Scholar
• Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008; 28:675 - 86; http://dx.doi.org/10.1016/j.immuni.2008.03.011; PMID: 18424188
   PubMed Web of Science ®Google Scholar
• Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 1999; 163:5278 - 86; PMID: 10553050
   PubMed Web of Science ®Google Scholar
• Guo B, Chang EY, Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 2008; 118:1680 - 90; http://dx.doi.org/10.1172/JCI33342; PMID: 18382764
   PubMed Web of Science ®Google Scholar
• Liu L, Okada S, Kong X-F, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011; 208:1635 - 48; http://dx.doi.org/10.1084/jem.20110958; PMID: 21727188
   PubMed Web of Science ®Google Scholar
• Wong P, Severns CW, Guyer NB, Wright TM. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol Cell Biol 1994; 14:914 - 22; PMID: 8289831
   PubMed Web of Science ®Google Scholar
• Ohmori Y, Hamilton TA. Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol 2001; 69:598 - 604; PMID: 11310846
   PubMed Web of Science ®Google Scholar
• Hu Y, Hu X, Boumsell L, Ivashkiv LB. IFN-gamma and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways. J Immunol 2008; 180:8057 - 65; PMID: 18523269
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13:453 - 61; http://dx.doi.org/10.2741/2692; PMID: 17981560
   PubMed Web of Science ®Google Scholar
• Pekarek V, Srinivas S, Eskdale J, Gallagher G. Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 2007; 8:177 - 80; http://dx.doi.org/10.1038/sj.gene.6364372; PMID: 17252004
   PubMed Web of Science ®Google Scholar
• Wang J, Campbell IL. Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon. J Virol 2005; 79:8295 - 302; http://dx.doi.org/10.1128/JVI.79.13.8295-8302.2005; PMID: 15956575
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Chaudhri G, Tan CL, John A, Foster PS, Karupiah G. Transcription of the interferon gamma (IFN-gamma)-inducible chemokine Mig in IFN-gamma-deficient mice. J Biol Chem 2001; 276:7568 - 74; http://dx.doi.org/10.1074/jbc.M005773200; PMID: 11024052
   PubMed Web of Science ®Google Scholar
• Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, et al. IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling. PLoS Pathog 2013; 9:e1003118; http://dx.doi.org/10.1371/journal.ppat.1003118; PMID: 23300459
   PubMedGoogle Scholar
• Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, Farber J, et al. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 2001; 158:1433 - 40; http://dx.doi.org/10.1016/S0002-9440(10)64094-1; PMID: 11290561
   PubMed Web of Science ®Google Scholar
• Souto JT, Aliberti JC, Campanelli AP, Livonesi MC, Maffei CM, Ferreira BR, et al. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-gamma. Am J Pathol 2003; 163:583 - 90; http://dx.doi.org/10.1016/S0002-9440(10)63686-3; PMID: 12875978
   PubMed Web of Science ®Google Scholar
• Jaruga B, Hong F, Kim W-H, Gao B. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 2004; 287:G1044 - 52; http://dx.doi.org/10.1152/ajpgi.00184.2004; PMID: 15246962
   PubMed Web of Science ®Google Scholar
• Buttmann M, Merzyn C, Rieckmann P. Interferon-β induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis. J Neuroimmunol 2004; 156:195 - 203; http://dx.doi.org/10.1016/j.jneuroim.2004.07.016; PMID: 15465611
   PubMed Web of Science ®Google Scholar